Liu Jianfeng, Johnson Bernard, Wu Ruyan, Seaman Robert, Vu Jimmy, Zhu Qing, Zhang Yanan, Li Jun-Xu
Department of Pharmacology and Toxicology, University at Buffalo, Buffalo, New York, USA.
School of Medicine, Yangzhou University, Yangzhou, China.
Br J Pharmacol. 2020 Aug;177(15):3403-3414. doi: 10.1111/bph.15061. Epub 2020 May 5.
The trace amine-associated receptor 1 (TAAR1) negatively modulates dopamine transmission. Our previous studies demonstrated that TAAR1 agonists attenuated cue- and drug-induced cocaine-seeking and increased the elasticity of the cocaine demand curve, in the short-access cocaine self-administration model. Compulsive use of cocaine, which is an essential criterion of cocaine use disorder, can be induced by extended access to cocaine self-administration.
To characterize the role of TAAR1 in compulsive cocaine use, we evaluated the effects of activation of TAAR1 on cocaine intake, cocaine binge and cue-induced cocaine-seeking using the extended-access cocaine self-administration model in adult male Sprague-Dawley rats. We also investigated the role of TAAR1 in stress-triggered cocaine relapse by using the α -adrenoceptor antagonist yohimbine-induced reinstatement of cocaine-seeking.
The selective TAAR1 partial agonist RO5263397 attenuated cocaine intake and did not develop tolerance during the 10-day extended-access cocaine self-administration. RO5263397 reduced a 12-h binge intake of cocaine after forced abstinence. RO5263397 also decreased cue-induced cocaine-seeking after prolonged abstinence from extended-access cocaine self-administration. Furthermore, RO5263397 and the selective TAAR1 full agonist RO5166017 reduced yohimbine-induced reinstatement of cocaine-seeking behaviour.
Activation of TAAR1 attenuated extended-access cocaine self-administration and stress-induced cocaine reinstatement. These results suggest that TAAR1 agonists are promising pharmacological interventions to treat cocaine use disorder and relapse.
痕量胺相关受体1(TAAR1)对多巴胺传递起负性调节作用。我们之前的研究表明,在短期可获得可卡因自我给药模型中,TAAR1激动剂可减弱线索和药物诱导的觅药行为,并增加可卡因需求曲线的弹性。可卡因使用障碍的一个重要标准是强迫性使用可卡因,延长可获得可卡因自我给药的时间可诱导这种行为。
为了明确TAAR1在强迫性使用可卡因中的作用,我们在成年雄性Sprague-Dawley大鼠中,使用延长可获得可卡因自我给药模型,评估激活TAAR1对可卡因摄入量、可卡因 binge 及线索诱导的觅药行为的影响。我们还通过使用α-肾上腺素能受体拮抗剂育亨宾诱导的可卡因觅药行为恢复,研究TAAR1在应激触发的可卡因复发中的作用。
选择性TAAR1部分激动剂RO5263397在10天延长可获得可卡因自我给药期间减弱了可卡因摄入量,且未产生耐受性。RO5263397减少了强制戒断后12小时的可卡因 binge 摄入量。RO5263397还减少了长期戒断延长可获得可卡因自我给药后线索诱导的觅药行为。此外,RO5263397和选择性TAAR1完全激动剂RO5166017减少了育亨宾诱导的可卡因觅药行为恢复。
激活TAAR1减弱了延长可获得可卡因自我给药及应激诱导的可卡因复吸。这些结果表明,TAAR1激动剂是治疗可卡因使用障碍和复发的有前景的药理学干预措施。